Article: Xhale Wins NIH / NIMH SBIR Phase II Grant for a Breath-Based Medication Adherence System


Wireless News
08-29-2009
Xhale Wins NIH / NIMH SBIR Phase II Grant for a Breath-Based Medication Adherence System
Type: News

Xhale, Inc. has been awarded a $1.7 million Small Business Innovation Research (SBIR) Phase II grant by the NIH National Institute of Mental Health (NIMH) to continue the development of SMART (Self Monitoring and Reporting Therapeutics), a breath-based medication adherence system for HIV/AIDS therapies.

In a release, the Company noted:
In 2007, NIH / NIMH awarded Xhale an SBIR Phase I grant to test the technical merit of SMART. SBIR Phase II grants enable SBIR Phase I grantees to further develop their technology and prepare it for commercialization. Xhale will use ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!